We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Allergy Therapeutics Plc | AGY | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.90 | 08:35:16 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.90 | 2.90 | 2.95 | 2.90 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 03/11/2023 08:18 by beccasan I believe that Chinese funds will long remember the big mistake they made by putting money into this company. Mistake that everyone in Europe and beyond has made throughout the history of this company. A company that we often describe as a high tech life science startup but that I remind myself has products that it wants to register that are over twenty years old. This company, chronically hungry for money, on the brink of collapse for decades and which has burned millions of pounds because it was governed by inadequate managers, now had to look for a Chinese investor to screw, because everyone available had already been screwed. |
Posted at 29/9/2023 10:44 by jpuff So what is the point of the AIM market then when it's just riddled with crooks just out to feather their own nests at the expense of hard working small investors? Shouldn't the authorities just close it down or put out a warning like 9 out of 10 investors will lose all their money here? |
Posted at 11/8/2023 20:12 by vergeltung @JpuffYou are perhaps right, perhaps there should be an investigation. Unfortunately there is no court of basic business competence - so by whom? - The Stock Exchange (they were not transparent in their AIM announcements and might have created a false market. This might involve their advisors too, in particular counsel and NOMAD) - The police (if there was a fraudulent combination between management and the main investors) - The financial ombudsman We should wait and see what the board and main shareholders do now - they have so many opportunities to shaft us further .. If they extend their greed too far I would for sure support an attempt to bring them to justice. |
Posted at 10/8/2023 13:42 by 1kckeith This company has become some kind of corporate clown, blundering around the AIM stage in enormous comedic shoes, ‘accidentally&Our genius board and its advisors have managed to produce a situation where: 1. Investors are not investors. A major Insider Shareholder since years still does not have an Foreign Direct Investor (FDI) clearance. 2. The board is not in control (I). If this FDI approval is not forthcoming the Insider gets the company for nothing; who controls the process? (hint: the Insider! Actually it only needs use ‘reasonable endeavours’ re the FDI) 3. Good is Bad. If AGY too quickly achieves its biggest objective, striven for almost since the company’s foundation - a successful outcome for G306 - it is likely to be disastrous for shareholders. 4. More is less. If, against the odds, shareholders do get to subscribe in the largest fund-raise the company has ever had, AGY will still need more financing within months 5. The Board is not in control (II). AGY is in discussion with ‘certain shareholders’ (hint: the Insiders, SkyGem and Southern Fox) re financing after October. Hmm – who holds all the cards here? (hint: see previous hint) 6. Minus 20% is slight. Amazingly, even after last year’s cretinous shut-down, if AGY produces clinical trial material now it cannot make enough product for sale too, so projected sales will be ‘slightly lower’ than this year’s - which were short-supplied by the ‘short term pause in production’ aka the cretinous shut-down 7. The worthless is prioritised, the Important concealed. Fair value accounting: 33m warrants to buy shares at 30p is worthy of first mention (hint: it’s zero) but the known repayment premium on the Loan Facility comes second and is not quantified (hint: it’s huge at 250% and unaffordable). 8. Heads they win; tails, they don’t lose. The premium is payable if G306 is successful and the last FDI approval is not received by Jan 2024. Or if for any other reason the Equity Financing does not happen. Or if G306 is a failure. I could go on. Major worries are that October financing (what happens if it pre-dates the Equity Financing? What sort of punitive terms will the Insiders force down our throats when it does happen?) and the slim likelihood of the Open Offer actually happening. Like most clowns, this one is more terrifying than funny. |
Posted at 01/8/2023 15:44 by farmergeorge timebo003, that makes sense, thanks. I've been out of the loop, but has the option to buy at 1p been offered to investors? |
Posted at 01/8/2023 15:34 by timbo003 Thanks for your unique insight KmcK, I have sent you a PM via the ADVFN messaging service.>>>>farm |
Posted at 31/7/2023 20:58 by timbo003 AGM ReportToday's AGM was held at the offices of the company’s solicitors, Cooley (UK) which is located at 22 Bishopgate EC2N 4BQ, it took quite a while to gain access due to various security measures, so if you ever visit anyone in that that building make sure you let them know ahead of your arrival. When I arrived I commented to Peter Jensen (PJ) that I had received no information from AJ Bell (where I hold most of my AGY shares) about the meeting and I was only aware of the meeting through holding a small number of shares as certificates which meant I got a notification through snail mail. PJ then introduced me to the company secretary (Karley Cheeseman) who said she would look into the matter, but judging by the low attendance at the meeting (I was the only retail shareholder present) I suspect I was not the only retail shareholder who had not been informed about the meeting. There were three directors present all non-execs: Peter Jensen, Mary Tavener and Anthony Parker (Southern Fox). Apparently Manuel Llobet (CEO) and Simon Shen (ZQ Capital) joined by video link, but I couldn’t see them and they didn’t appear to participate in the proceedings There were only two resolutions put to shareholders on this occasion, the first was to approve the accounts and the second was to approve the remuneration report. Having just perused the section on director’s remuneration I had a question regarding the performance related portion of the director’s remuneration. For the year in question the CEO was paid approximately £664k, which comprised £388k basic and £276k performance related, so I questioned whether there should have been a performance related payment for any of the executive directors given the appalling share price performance last year. PJ responded by saying that financial year 2022 ended in June 2022 and the factory shut down occurred after the end of the financial year 2022, however for the subsequent year the performance related payment for the CEO would be zero. That seemed like a satisfactory response to me, so I voted to approve resolution 1 and 2. PJ then closed the formal meeting and allocated me about 15 minutes to ask questions about the business. Given the time constraint I had questions on just two topics, 1) the background to the shutdown last year and the apparent lack of forward planning and contingency plans 2) the forthcoming open offer to shareholders. Shutdown: I questioned why they hadn’t stockpiled product before the shutdown or put in place other contingency plans. PJ responded by saying that everything they could say on the matter was laid out in the RNS statements dated 6th April 2022, they were not able to expand on that. It was not through choice they shut down when they did, but it was necessary to do so due to regulatory (MHRA) concerns. Fund raise: I commented that now the share price had risen considerably above the proposed 1p open offer price, and then asked whether they would consider modifying the offer to raise the same amount of money but by issuing (for example) half the number of shares at 2p/share. This would be of particular benefit to shareholders who were not able to participate in the forthcoming raise for whatever reason. PJ turned to the Lawyer (Simon from Cooley UK) to answer that one. Apparently it is not possible as legal documents have now been signed by the company and proposed funders regarding the proposals for a raise at 1p/share. PJ then took the opportunity to state that he intended to take up the offer in full with his 300K shares, I responded by saying that I intended to do likewise but with a smaller shareholding and allocation. I then asked for confirmation that there would be no funds raised from new outside investors (i.e. no accompanying placing which may attract short term flippers), PJ confirmed there would be no accompanying placing. I also asked whether ordinary shareholders would be able to apply for additional excess shares in addition to their basic allocation, the answer was no, all shares not taken up in the open offer would be purchased by ZQ Capital who are underwriting the offer. After the meeting had come to an end, Simon (the lawyer) filled in a couple more gaps on the funding: The open offer cannot/will not take place until they have foreign direct investment (FDI) clearance from four Jurisdictions (interestingly the UK is not one of the four). In theory this should be easy (especially considering the nature of AGY’s business), but in practice it is more prolonged and complicated than anticipated. The company will issue RNS statements on this should there be any significant developments on this which could affect timings. |
Posted at 05/7/2023 16:48 by farmergeorge Well, there are two views. It will go up or it will go down. Assuming an an even split, 50% of investors will have a pleasant surprise. So, I'm saying it will go down and the opposite will happen. |
Posted at 23/6/2023 12:04 by farmergeorge So, we now have a new financial category of investors emerging - 'certified investors'. Before long, their investment performance will be compared agaist benchmarks. |
Posted at 12/4/2023 21:59 by stablehound I agree with you 1kckeith, if we are not to be wiped out there is no alternative but to follow the money. There seem to be two things to consider, firstly, all that has gone before has to be put out of one’s mind and the fact that we have all probably lost a great deal of our original investment is history. Secondly, the company is now effectively controlled by, I would suspect, a couple of pretty sharp private equity/ venture capital investors. It is not in their interest to turn the established order upside down right now but I would guess their hand are very much on the controls and when the time is right I hope and believe they will put in people better able to achieve their objectives than the skeleton crew who are currently supposedly at the helm. They will be keen to get through this time without any further tsunamis.So, we may well now have an opportunity to venture a penny a share with the potential of something better so long as the wheels don’t come off the cash flow projections in the coming fairly precarious months. One aside but nonetheless quite an interesting aspect is that the Company no longer has any charges over its assets, following the recent removal of the NatWest fixed and floating charge. It’s not often that a company teaters on the edge of bankruptcy with wholly unencumbered assets. This situation will presumably change as soon as the investors put up their temporary loan capital. If things then go wrong for any reason and there is a breach in the covenant conditions you can be sure they will swoop and take 100% control wiping out the minorities at a stroke. This should be more difficult for them to do once the new shares have all be subscribed but the the documents would have to be examined very carefully to establish whether that is the case. Nil desperandum |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
